False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma
Y Inoue, MD
1
M Akahane, MD
1
T Kitazawa, MD
2
H Ijichi, MD
2
S Obi, MD
2
K Yoshikawa, MD
1
K Ohtomo, MD
3 and
M Omata, MD
2
1 Department of Radiology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639 and Departments of 2 Gastroenterology and 3 Radiology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan
View larger version (174K):
[in a new window]
|
Figure 1. Anterior abdominal image obtained 4 h postinjection of 123I-metaiodobenzylguanidine. Photopenic areas are seen in the liver.
|
|
View larger version (175K):
[in a new window]
|
Figure 2. Anterior abdominal view obtained 24 h post injection of 123I-metaiodobenzylguanidine. Inhomogeneously increased uptake is noted in the liver.
|
|
View larger version (107K):
[in a new window]
|
Figure 3. CT of the upper abdomen imaged during the portal venous phase after contrast medium injection. A large mass lesion is demonstrated in the liver.
|
|
Copyright © 2002 by the British Institute of Radiology.
